Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Galantamine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01416948
What this trial is testing

Cognitive REmediation After Trauma Exposure Trial = CREATE Trial

Who this might be right for
Posttraumatic Stress DisorderTraumatic Brain Injury
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium 32
Post-approval studies (Phase 4)Study completedNCT00164242
What this trial is testing

Treatment of Tardive Dyskinesia With Galantamine

Who this might be right for
Tardive Dyskinesia
Caroff, Stanley N., M.D. 36
Not applicableStudy completedNCT00606801
What this trial is testing

Galantamine Effects on Cognitive Function in Abstinent Cocaine Users

Who this might be right for
Cocaine Abuse
Yale University 34
Testing effectiveness (Phase 2)Study completedNCT00416169
What this trial is testing

A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia

Who this might be right for
Frontotemporal DementiaPick Complex
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 41
Post-approval studies (Phase 4)Study completedNCT00741598
What this trial is testing

Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder

Who this might be right for
Bipolar Disorder
Icahn School of Medicine at Mount Sinai 72
Early research (Phase 1)Study completedNCT00969696
What this trial is testing

Galantamine Effects on Cognitive Function in Marijuana Users

Who this might be right for
Memory
Yale University 29
Large-scale testing (Phase 3)Looking for participantsNCT07625332
What this trial is testing

Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)

Who this might be right for
Spinal Cord InjuryTraumatic Spinal Cord InjuryParaplegia and Tetraplegia+1 more
Northwell Health 60
Large-scale testing (Phase 3)Study completedNCT00216502
What this trial is testing

The Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaMental Disorders+1 more
Janssen-Cilag S.p.A. 254
Early research (Phase 1)Active Not RecruitingNCT03124355
What this trial is testing

Vagal Stimulation in POTS

Who this might be right for
Postural Tachycardia Syndrome
Vanderbilt University Medical Center 11
Not applicableStudy completedNCT00297362
What this trial is testing

The Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Cilag Pharmaceutica S.A.C.I., Greece 344
Post-approval studies (Phase 4)Study completedNCT00227994
What this trial is testing

Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke

Who this might be right for
Cerebrovascular Accident
University of Pittsburgh 40
Large-scale testing (Phase 3)Study completedNCT00338117
What this trial is testing

Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 554
Large-scale testing (Phase 3)Study completedNCT00261573
What this trial is testing

The Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia

Who this might be right for
Alzheimer DiseaseVascular Dementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 593
Early research (Phase 1)Study completedNCT00750529
What this trial is testing

Alzheimer and Sleep

Who this might be right for
Alzheimer's Disease
University Hospital, Clermont-Ferrand 15
Post-approval studies (Phase 4)Study completedNCT02703636
What this trial is testing

NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.

Who this might be right for
Mild to Moderate Alzheimer's Disease
Novartis Pharmaceuticals 118
Large-scale testing (Phase 3)Study completedNCT00301574
What this trial is testing

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
Janssen Pharmaceutical K.K. 398
Post-approval studies (Phase 4)Study completedNCT00181675
What this trial is testing

Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder

Who this might be right for
ADHD
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00509067
What this trial is testing

Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia

Who this might be right for
Schizophrenia
Georgetown University 43
Large-scale testing (Phase 3)Study completedNCT00645190
What this trial is testing

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Xian-Janssen Pharmaceutical Ltd. 215
Post-approval studies (Phase 4)Study completedNCT00035204
What this trial is testing

The Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63
Next Page